Editorial Cuvillier

Publicaciones, tesis doctorales, capacitaciónes para acceder a una cátedra de universidad & prospectos.
Su editorial internacional especializado en ciencias y economia

Editorial Cuvillier

De En Es
The Compatibility of the Access to Essential Generic Medicines with Human Rights: An Analysis of the In-Transit Seizure of Essential Generic Medicines from India by the European Union

Impresion
EUR 99,90

E-Book
EUR 69,90

The Compatibility of the Access to Essential Generic Medicines with Human Rights: An Analysis of the In-Transit Seizure of Essential Generic Medicines from India by the European Union (Tienda española)

Sanjeev Thavarajah (Autor)

Previo

Lectura de prueba, PDF (160 KB)
Indice, PDF (100 KB)

The Covid-19 pandemic has sensitised the global community on the
importance of the access to essential medicines. The nations of the world have engaged in a fierce battle over the lifesaving Covid-19 vaccines, in which developed nations have come out successfully. The access to essential medicines has long been promoted by the United Nations (UN) and other international human rights organisations. In this context, India seems to have done its bit and has emerged as the pharmacy of the developing world and further has been providing the global poor with the advantage of access to essential as well as generic drugs.

ISBN-13 (Impresion) 9783736979017
ISBN-13 (E-Book) 9783736969018
Idioma Inglés
Numero de paginas 412
Laminacion de la cubierta mate
Edicion 1
Lugar de publicacion Göttingen
Fecha de publicacion 20.10.2023
Clasificacion simple Libro de divulgacion
Area Derecho
Economía
Ciencias sociales
Teoría de la medicina
Farmacia
Palabras claves generische Arzneimittel; In-Transit-Beschlagnahme; Urheberrecht ; Indien; Europäische Union; Recht auf Gesundheit; Evergreening; Zwangslizenzen; GATT; Patent- und Markenamt der Vereinigten Staaten; TRIPS; Bayer Corporation; Traditionelles Wissen; Freihandelsabkommen; Protektionismus; SARS-CoV-2; United States Patent Act; Biopiraterie; Welthandelsorganisation; WIPO; Brexit; Multilateralismus; Covid-19-Pandemie; Internationale Menschenrechte; EU Verordnung 1383/2003; Pharmazeutika; HIV/AIDS; Gomutra, Corona-Virus; Weltgesundheitsorganisation; Anti-Krebs-Therapie; Losartan; Herstellungsfiktion; Doha-Erklärung; antimikrobielle Resistenz; antiretrovirale Medikamente; Lex Specialis ; Berufungsgremium der Welthandelsorganisation; Normenkonflikt; Parallelimporte